Funding
The group is currently supported by:
2023 – 2027 China Scholarship Council (CSC) stipend for Mr. Liangliang Lia from Shanghai Xiaotong University
2023 – 2026 Funding of the German Research foundation for development of novel carriers for nucleic acids
2023 – 2024 RWTH grant ERS with Prof. Andreas Herrmann
2023 – 2025 Funding from the state of NRW for establishing explant cultures (NovoKolon - ZukunftBio.NRW)
2022 – 2026 BMBF funding for replacing animal experiments
2022 - 2026 China Scholarship Council (CSC) stipend for Mr. Liangliang Liao from Qilin University
2020 - 2024 China Scholarship Council (CSC) stipend for Mr. Cheng Lin from Shanghai Xiaotong University
2019 - 2021 Grant of the Wilhelm Sander foundation for the modulation of myeloid cells in hepatocarcinogenesis (grant no.2018.129.1), two years
2019 - 2022 Grant of the German Research Foundation for nanocarriers for small-non coding RNA to treat liver diseases, three years
Completed research support:
2019 - 2020 Long term stipend with the German Academic Exchange Service (DAAD) GERLS Call 2018/2019.
COST Action BM1404 Mye-EUNITER which is part of the European Union Framework Program Horizon 2020 (http://www.mye-euniter.eu)
2016-2017 Wilhelm Sander Foundation The role of monocytic immune cells for hepatocarcinogenesis and releance of therapeutic modulation of CCR2-dependent invasion and differentiation
2014-2015 START-Programm der Medizinischen Fakultät der RWTH-Aachen
2007-2010 DFG fellow in the graduate school „Biointerface“
